Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannes Sallmon

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Journal of Perinatology : Official Journal of the California Perinatal Association|April 2, 2022
Extremely premature infants born at 23-25 weeks gestation are at substantial risk for pulmonary hypertensionHannes Sallmon, Martin Koestenberger, Alexander Avian, et al.
Clinical Cardiology|June 14, 2018
Right ventricular base/apex ratio in the assessment of pediatric pulmonary arterial hypertension: Results from the European Pediatric Pulmonary Vascular Disease NetworkMartin Koestenberger, Alexander Avian, Andreas Gamillscheg, et al.
Heart (British Cardiac Society)|February 13, 2016
Galectin-3 and aldosterone as potential tandem biomarkers in pulmonary arterial hypertensionLaurent Calvier, Ekaterina Legchenko, Lena Grimm, et al.
Frontiers in Cardiovascular Medicine|October 8, 2024
Home-based long-term physical endurance and inspiratory muscle training in children and adults with Fontan circulationLena Walzer, Hannes Sallmon, Marcus Kelm, et al.
Cardiovascular Diagnosis and Therapy|November 23, 2020
Safety and efficacy of the endothelin receptor antagonist macitentan in pediatric pulmonary hypertensionSabrina Schweintzger, Martin Koestenberger, Axel Schlagenhauf, et al.
International Journal of Molecular Sciences|August 27, 2021
Soluble Receptor for Advanced Glycation End Products (sRAGE) Is a Sensitive Biomarker in Human Pulmonary Arterial HypertensionFranziska Diekmann, Philippe Chouvarine, Hannes Sallmon, et al.
Pediatrics|August 8, 2012
Thrombocytopenia in the first 24 hours after birth and incidence of patent ductus arteriosusHannes Sallmon, Sven C Weber, Britta Hüning, et al.
Frontiers in Pediatrics|March 23, 2018
Association between Platelet Counts before and during Pharmacological Therapy for Patent Ductus Arteriosus and Treatment Failure in Preterm InfantsHannes Sallmon, Sven C Weber, Juliane Dirks, et al.
Pulmonary Circulation|December 25, 2023
Current diagnosis and treatment practice for pulmonary hypertension in bronchopulmonary dysplasia-A survey study in Germany (PUsH BPD)Friederike Häfner, Caroline Johansson, Larissa Schwarzkopf, et al.
Frontiers in Cardiovascular Medicine|January 10, 2022
Morphologic Alterations Precede Functional Hepatic Impairment as Determined by <sup>13</sup>C-Methacetin Liver Function Breath Test in Adult Fontan PatientsAnastasia Schleiger, Peter Kramer, Hannes Sallmon, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Journal of Perinatology : Official Journal of the California Perinatal Association|April 2, 2022
Extremely premature infants born at 23-25 weeks gestation are at substantial risk for pulmonary hypertensionHannes Sallmon, Martin Koestenberger, Alexander Avian, et al.
Clinical Cardiology|June 14, 2018
Right ventricular base/apex ratio in the assessment of pediatric pulmonary arterial hypertension: Results from the European Pediatric Pulmonary Vascular Disease NetworkMartin Koestenberger, Alexander Avian, Andreas Gamillscheg, et al.
Heart (British Cardiac Society)|February 13, 2016
Galectin-3 and aldosterone as potential tandem biomarkers in pulmonary arterial hypertensionLaurent Calvier, Ekaterina Legchenko, Lena Grimm, et al.
Frontiers in Cardiovascular Medicine|October 8, 2024
Home-based long-term physical endurance and inspiratory muscle training in children and adults with Fontan circulationLena Walzer, Hannes Sallmon, Marcus Kelm, et al.
Cardiovascular Diagnosis and Therapy|November 23, 2020
Safety and efficacy of the endothelin receptor antagonist macitentan in pediatric pulmonary hypertensionSabrina Schweintzger, Martin Koestenberger, Axel Schlagenhauf, et al.
International Journal of Molecular Sciences|August 27, 2021
Soluble Receptor for Advanced Glycation End Products (sRAGE) Is a Sensitive Biomarker in Human Pulmonary Arterial HypertensionFranziska Diekmann, Philippe Chouvarine, Hannes Sallmon, et al.
Pediatrics|August 8, 2012
Thrombocytopenia in the first 24 hours after birth and incidence of patent ductus arteriosusHannes Sallmon, Sven C Weber, Britta Hüning, et al.
Frontiers in Pediatrics|March 23, 2018
Association between Platelet Counts before and during Pharmacological Therapy for Patent Ductus Arteriosus and Treatment Failure in Preterm InfantsHannes Sallmon, Sven C Weber, Juliane Dirks, et al.
Pulmonary Circulation|December 25, 2023
Current diagnosis and treatment practice for pulmonary hypertension in bronchopulmonary dysplasia-A survey study in Germany (PUsH BPD)Friederike Häfner, Caroline Johansson, Larissa Schwarzkopf, et al.
Frontiers in Cardiovascular Medicine|January 10, 2022
Morphologic Alterations Precede Functional Hepatic Impairment as Determined by <sup>13</sup>C-Methacetin Liver Function Breath Test in Adult Fontan PatientsAnastasia Schleiger, Peter Kramer, Hannes Sallmon, et al.
Pageof 6